Decalcifying Composition for Cardiovascular Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cardiovascular disease, such as expensive and invasive surgeries, and drugs with harmful side effects, are inadequate in addressing the underlying causes of cardiovascular disease and providing a non-invasive, cost-effective solution.
Innovation Solution
A decalcifying composition comprising sodium citrate, vitamin C, and L-lysine, which uses chelation therapy to non-invasively decalcify blood vessels, addressing the underlying cause of cardiovascular disease.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional drugs and surgeries are used to treat cardiovascular disease, then treatment effectiveness may be improved, but harmful side effects and invasiveness increase
Solution Approach 1:
The patent employs naturally derived chelating agents (citric acid, EDTA, polyphosphates) that are administered orally or intravenously as temporary therapeutic agents. These short-acting chelating substances bind to calcium in plaque temporarily, allowing gradual plaque softening and removal without long-term accumulation of harmful substances in the body.
Solution Approach 2:
The invention changes the chemical parameters of the plaque by introducing chelating agents that alter the calcium-carbonate structure. The chelating agents modify the plaque composition by binding calcium ions, transforming the hard calcified plaque into a softer, more permeable structure that can be gradually removed by the body's natural processes.
2Reliability
If expensive surgeries and drugs are used for cardiovascular disease treatment, then treatment capability is improved, but cost increases
Solution Approach 1:
The patent utilizes inexpensive, naturally derived chelating agents that can be administered orally or intravenously. These cheap therapeutic substances (citric acid from fruits, EDTA from natural sources, polyphosphates from food) provide effective plaque treatment without the high costs associated with surgical procedures or prescription medications.
Solution Approach 2:
The invention leverages the body's own natural mechanisms for plaque removal by using chelating agents that work with the body's metabolic processes. The body's enzymes and cellular processes naturally break down and remove the softened plaque, eliminating the need for expensive surgical interventions.
3Ease of operation
If invasive surgery is performed to fix cardiovascular disease, then immediate symptom relief is achieved, but recovery time and complexity increase
Solution Approach 1:
The patent replaces mechanical surgical interventions (stents, bypass surgery, plaque removal procedures) with a chemical-biological approach using chelating agents. Instead of mechanically cutting, inserting, or removing plaque through surgery, the treatment uses chemical chelation to soften and dissolve plaque in place, eliminating the need for complex surgical devices and procedures.
Solution Approach 2:
The body's natural metabolic and enzymatic systems perform the plaque removal function that would otherwise require surgical intervention. The chelating agents initiate a process where the body's own cells and enzymes gradually break down and eliminate the softened plaque, eliminating the need for surgical recovery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reverses calcified vascular systems, repairs arteries, and provides a safer, more cost-effective alternative to traditional treatments for cardiovascular disease.
Implementation Method 1
The present subject matter makes use of 'chelation therapy' to de-calcify blood vessels by using non-toxic organic ingredients.
Implementation Method 2
A decalcifying composition comprising sodium citrate, vitamin C, and L-lysine, which uses chelation therapy to non-invasively decalcify blood vessels
Data Source
AI summary
Disclosed are decalcification compositions for the treatment and prevention of cardiovascular disease and methods of administering such compositions to patients.